Although muscle-invasive disease is often treated by removal of the bladder, experts reveal potential high risk of death. Standard treatment for patients with muscle-invasive bladder cancer is radical ...

When Jodi Byfuglin, 56, was diagnosed with bladder cancer, it felt like cruel irony. Byfuglin had lost both her parents to cancer in their 50s, and as a single mother of two, she was all her kids had ...

Removal of the bladder, called radical cystectomy, is the preferred treatment for patients with muscle-invasive bladder cancer (MIBC) as well as for some with non-muscle-invasive bladder cancer (NMIBC ...

Partial cystectomy for muscle-invasive bladder cancer offers metastasis- and cancer-free survival comparable to that of radical cystectomy, but with less perioperative morbidity. Partial and radical ...

Use of robot-assisted vs. open radical cystectomy led to a significantly increased number of days alive and out of the hospital among patients with nonmetastatic bladder cancer. Perspective from David ...

Although radical cystectomy is an effective treatment for bladder cancer, it can have negative effects on urinary and sexual function. Lane et al. have performed nerve-sparing and ...

A 30-day course of prophylactic antibiotics following robot-assisted radical cystectomy significantly reduces the incidence of urinary tract infections (UTIs) and related complications, researchers ...

"We found CKD to be independently associated with a higher likelihood of nonorgan confined disease and lymph node metastases as well as postoperative transfusion and 90-day readmissions." – Nguyen, et ...

Perioperative management for muscle invasive bladder cancer (MIBC) includes neoadjuvant cisplatin-based chemotherapy (NAC) followed by radical cystectomy and risk-adapted adjuvant immunotherapy. More ...

Synchronous metastatic disease is characterized by the presence of metastatic lesions, in addition to the primary tumor, at diagnosis. The optimal duration of antibiotic prophylaxis is still unknown.